Using a panel of chemical inhibitors of various proteins previously reported to be activated by CagA32, we found that MEK1/2 inhibitors downregulated the expression of AGPS and AGPAT3, thereby decreasing sensitivity to ferroptosis in CagA-positive GC cells. The gene discussed is AGPS; the disease is gastric cancer.